Our annual review for 2025 highlights a year defined by the launch of our new five-year strategic roadmap. Our work remains focused on integrating emerging health technologies, digital infrastructure, and personalised prevention; a direction that directly aligns with the UK Government’s ten-year health plan.
This year’s review showcases our impact both domestically and internationally, including our leadership in convening a landmark global genomics summit in Canada.
With an opening perspective from Director Dr. Pete Mills, the annual review sets out how our expert analysis and cross-sector collaborations continue to drive the ethical and equitable application of science to improve population health.
